Proteomic profiling of a biomimetic drug delivery platform

Current Drug Targets

Volumn 16, Issue 13, 2015, Pages 1540-1547

  Corbo, Claudia ^a   Parodi, Alessandro ^a,b   Evangelopoulos, Michael ^b   Engler, David A ^c   Matsunami, Risë K ^c   Engler, Anthony C ^b   Molinaro, Roberto ^b,d   Scaria, Shilpa ^b   Salvatore, Francesco ^a,e   Tasciotti, Ennio ^b  

^a IRCCS SDN   (Italy)

^b Department of Nanomedicine ^*  (United States)

^c HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF PADOVA   (Italy)

^e CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

Bio mimetic camouflage; Drug delivery; Leukocyte; Leukolike vector; Membrane; Nanoparticles; Nanotechnology; Proteomics

Indexed keywords

BIOMIMETIC MATERIAL; CELL MARKER; SILICON; TRYPSIN; NANOPARTICLE; PROTEIN;

ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; BIOINFORMATICS; CELL CULTURE; CELL MEMBRANE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG SAFETY; DRUG SYNTHESIS; DRUG TARGETING; FLOW CYTOMETRY; LEUKOCYTE; LEUKOCYTE MEMBRANE; LEUKOLIKE VECTOR; LIQUID CHROMATOGRAPHY; MACROPHAGE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PROCESS OPTIMIZATION; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEOMICS; SCANNING ELECTRON MICROSCOPY; ZETA POTENTIAL; ANIMAL; BIOMIMETICS; CELL LINE; CHEMISTRY; POROSITY; PROCEDURES;

ANIMALS; BIOMIMETICS; CELL LINE; CELL MEMBRANE; DRUG DELIVERY SYSTEMS; LEUKOCYTES; MICE; NANOPARTICLES; POROSITY; PROTEINS; PROTEOMICS; SILICON;

EID: 84946409682     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/1389450115666141109211413     Document Type: Article

References (35)

1. Veiseh O, Gunn JW, Zhang M. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev 2010; 62(3): 284-304.
2. Köhler K, Sukhorukov GB. Heat treatment of polyelectrolyte multilayer capsules: a versatile method for encapsulation. Adv Funct Mater 2007; 17(13): 2053-61.
3. Torchilin V. Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev 2011; 63(3): 131-5.
4. Du H, Chandaroy P, Hui SW. Grafted poly-(ethylene glycol) on lipid surfaces inhibits protein adsorption and cell adhesion. Biochim Biophys Acta 1997; 1326(2): 236-48.
5. van Vlerken LE, Vyas TK, Amiji MM. Poly (ethylene glycol)- modified nanocarriers for tumor-targeted and intracellular delivery. Pharm Res 2007; 24(8): 1405-14.
6. Vert M, Domurado D. Poly (ethylene glycol): Protein-repulsive or albumin-compatible? J Biomater Sci Polym Ed 2000; 11(12): 1307-17.
7. Knop K, Hoogenboom R, Fischer D, Schubert US. Poly (ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew Chem Int Ed Engl 2010; 49(36): 6288-308.
8. Caruso F. Nanoengineering of particle surfaces. Adv Mater 2001; 13(1): 11-22.
9. Hu C-MJ, Zhang L, Aryal S, Cheung C, Fang RH, Zhang L. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci USA 2011; 108(27): 10980-5.
10. Dou H, Destache CJ, Morehead JR, et al. Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery. Blood 2006; 108(8): 2827-35.
11. Klem MT, Willits D, Solis DJ, Belcher AM, Young M, Douglas T. Bio‐inspired Synthesis of Protein‐Encapsulated CoPt Nanoparticles. Adv Funct Mater 2005; 15(9): 1489-94.
12. Yoo J-W, Irvine DJ, Discher DE, Mitragotri S. Bio-inspired, bioengineered and biomimetic drug delivery carriers. Nat Rev Drug Discov 2011; 10(7): 521-35.
13. Parodi A, Quattrocchi N, van de Ven AL, et al. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat Nanotechnol 2012.
14. Carlos TM, Harlan JM. Membrane proteins involved in phagocyte adherence to endothelium. Immunol Rev 1990; 114(1): 5-28.
15. Wessel D, Flügge U-I. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal Biochem 1984; 138(1): 141-3.
16. Silva JC, Denny R, Dorschel CA, et al. Quantitative proteomic analysis by accurate mass retention time pairs. Anal Chem 2005; 77(7): 2187-200.
17. Silva JC, Gorenstein MV, Li G-Z, Vissers JP, Geromanos SJ. Absolute quantification of proteins by LCMSE a virtue of parallel MS acquisition. Mol Cell Proteomics 2006; 5(1): 144-56.
18. Geromanos SJ, Vissers JP, Silva JC, et al. The detection, correlation, and comparison of peptide precursor and product ions from data independent LC‐MS with data dependant LC-MS/MS. Proteomics 2009; 9(6): 1683-95.
19. Li GZ, Vissers JP, Silva JC, Golick D, Gorenstein MV, Geromanos SJ. Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures. Proteomics 2009; 9(6): 1696-719.
20. Wolfram J, Suri K, Huang Y, et al. Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells. J Microencapsul 2014: 1-7.
21. Corbo C, Orrù S, Gemei M, et al. Protein cross‐talk in CD133+ colon cancer cells indicates activation of the Wnt pathway and upregulation of SRp20 that is potentially involved in tumorigenicity. Proteomics 2012; 12(12): 2045-59.
22. Caterino M, Corbo C, Imperlini E, et al. Differential proteomic analysis in human cells subjected to ribosomal stress. Proteomics 2013; 13(7): 1220-7.
23. Gemei M, Corbo C, D'Alessio F, Di Noto R, Vento R, Del Vecchio L. Surface proteomic analysis of differentiated versus stem‐like osteosarcoma human cells. Proteomics 2013; 13(22): 3293-7.
24. Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell J. Mol Cell Biol 2000.
25. Loyet KM, Ouyang W, Eaton DL, Stults JT. Proteomic profiling of surface proteins on Th1 and Th2 cells. J Proteome Res 2005; 4(2): 400-9.
26. Liang X, Zhao J, Hajivandi M, et al. Quantification of membrane and membrane-bound proteins in normal and malignant breast cancer cells isolated from the same patient with primary breast carcinoma. J Proteome Res 2006; 5(10): 2632-41.
27. Rahbar AM, Fenselau C. Unbiased examination of changes in plasma membrane proteins in drug resistant cancer cells. J Proteome Res 2005; 4(6): 2148-53.
28. Lund R, Leth-Larsen R, Jensen ON, Ditzel HJ. Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers. J Proteome Res 2009; 8(6): 3078-90.
29. Durr E, Yu J, Krasinska KM, et al. Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nat biotechnol 2004; 22(8): 985-92.
30. Gao H, Liu J, Yang C, et al. The impact of PEGylation patterns on the in vivo biodistribution of mixed shell micelles. Int J Nanomedicine 2013; 8: 4229.
31. Millán J, Hewlett L, Glyn M, Toomre D, Clark P, Ridley AJ. Lymphocyte transcellular migration occurs through recruitment of endothelial ICAM-1 to caveola-and F-actin-rich domains. Nat Cell Biol 2006; 8(2): 113-23.
32. Walzog B, Gaehtgens P. Adhesion molecules: the path to a new understanding of acute inflammation. Physiology 2000; 15(3): 107-13.
33. van Vliet SJ, Gringhuis SI, Geijtenbeek TB, van Kooyk Y. Regulation of effector T cells by antigen-presenting cells via interaction of the C-type lectin MGL with CD45. Nat Immunol 2006; 7(11): 1200-8.
34. Hermiston ML, Zikherman J, Zhu JW. CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells. Immunol Rev 2009; 228(1): 288-311.
35. Lança T, Silva-Santos B. The split nature of tumor-infiltrating leukocytes: Implications for cancer surveillance and immunotherapy. Oncoimmunol 2012; 1(5): 717-25.